AU2001276716A1 - Cyclic amine derivatives and use thereof - Google Patents
Cyclic amine derivatives and use thereofInfo
- Publication number
- AU2001276716A1 AU2001276716A1 AU2001276716A AU7671601A AU2001276716A1 AU 2001276716 A1 AU2001276716 A1 AU 2001276716A1 AU 2001276716 A AU2001276716 A AU 2001276716A AU 7671601 A AU7671601 A AU 7671601A AU 2001276716 A1 AU2001276716 A1 AU 2001276716A1
- Authority
- AU
- Australia
- Prior art keywords
- cyclic amine
- amine derivatives
- derivatives
- cyclic
- amine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-239647 | 2000-08-08 | ||
JP2000239647 | 2000-08-08 | ||
PCT/JP2001/006673 WO2002012191A1 (fr) | 2000-08-08 | 2001-08-02 | Derives d'amines cycliques et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001276716A1 true AU2001276716A1 (en) | 2002-02-18 |
Family
ID=18731147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001276716A Abandoned AU2001276716A1 (en) | 2000-08-08 | 2001-08-02 | Cyclic amine derivatives and use thereof |
Country Status (3)
Country | Link |
---|---|
US (1) | US6949656B2 (fr) |
AU (1) | AU2001276716A1 (fr) |
WO (1) | WO2002012191A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003068744A1 (fr) * | 2002-02-18 | 2003-08-21 | Ishihara Sangyo Kaisha, Ltd. | Derives de la pyridine ou leurs sels, et inhibiteurs de production de citokine renfermant ces derives |
WO2005058834A2 (fr) | 2003-12-12 | 2005-06-30 | Wyeth | Quinolines convenant pour le traitement de maladies cardio-vasculaires |
JP4904026B2 (ja) * | 2004-08-04 | 2012-03-28 | 日本曹達株式会社 | 光反応性有機薄膜を形成する新規化合物及び有機薄膜形成体 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2960612D1 (en) | 1978-04-12 | 1981-11-12 | Ici Plc | Blood platelet aggregation inhibitory pyridine derivatives, pharmaceutical compositions thereof, and processes for their manufacture |
EP0004726B1 (fr) | 1978-04-12 | 1981-01-28 | Imperial Chemical Industries Plc | Dérivé de la tétrahydropyridine, inhibant l'agrégation des plaquettes sanguines, compositions pharmaceutiques les contenant et ses procédés de préparation |
GB2045750B (en) | 1979-03-16 | 1982-12-15 | Ici Ltd | Process for the manufacture of 1-benzyl-1,2,3,6-tetrahydropyridine derivatives |
FR2531707A1 (fr) * | 1982-08-16 | 1984-02-17 | Midy Spa | Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques |
JP2002501052A (ja) * | 1998-01-21 | 2002-01-15 | ミレニアム・ファーマシューティカルズ・インコーポレイテッド | ケモカイン受容体アンタゴニストおよびその使用方法 |
EP1066262A4 (fr) | 1998-03-25 | 2004-09-01 | Bristol Myers Squibb Co | Agents anorexigenes d'imidazolone: derives acycliques i |
EP0978512A1 (fr) * | 1998-07-29 | 2000-02-09 | Societe Civile Bioprojet | Non-imidazole aryloxy- (ou arylthio)alkylamines comme antagonistes du recepteur H3 et leur application thérapeutique |
EP1151993A4 (fr) * | 1999-02-08 | 2002-04-10 | Shionogi & Co | Derives d'amine cyclique et leurs utilisations |
-
2001
- 2001-08-02 AU AU2001276716A patent/AU2001276716A1/en not_active Abandoned
- 2001-08-02 WO PCT/JP2001/006673 patent/WO2002012191A1/fr active Application Filing
- 2001-08-02 US US10/296,388 patent/US6949656B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6949656B2 (en) | 2005-09-27 |
US20040038966A1 (en) | 2004-02-26 |
WO2002012191A1 (fr) | 2002-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001280187A1 (en) | Cyclic amine derivatives | |
AU2001234175A1 (en) | Novel cyclic amide derivatives | |
AU4796700A (en) | Ureido-substituted cyclic amine derivatives and their use as drug | |
AU4145200A (en) | Cyclic compounds and uses thereof | |
MXPA03006260A (es) | Derivados de amina sustituidos y metodos de uso. | |
AU2001277754A1 (en) | Proline derivatives and use thereof as drugs | |
AU2002235128A1 (en) | Expression miniarrays and uses thereof | |
EP1367060A4 (fr) | Derives glucopyranosyloxybenzylbenzene et leur utilisation medicale | |
EP1364957A4 (fr) | Derives de glycopyranosyloxypyrazole et utilisation medicinale de ceux-ci | |
EP1364958A4 (fr) | Derives de glycopyranosyloxypyrazole et utilisation medicinale de ceux-ci | |
HUP0300746A3 (en) | Proline derivatives and use thereof as drugs | |
AU2002226487A1 (en) | Novel c-glycoside derivatives and use thereof | |
AU8198901A (en) | Novel heteroaryl derivatives and use thereof as medicaments | |
AU2001287898A1 (en) | Pyrazolopyridines and pyrazolopyridazines as antidiabetics | |
AU2001267645A1 (en) | Cyclic urea compounds and preparation thereof | |
AU2002308891A1 (en) | Novel heterocyclic derivatives and medicinal use thereof | |
EP1392317A4 (fr) | 1-benzazepines substituees et leurs derives | |
EP1207882A4 (fr) | Derives d'amines acycliques et cycliques | |
AU2001264273A1 (en) | Amide compounds and use thereof | |
AU2001243601A1 (en) | Caprolactam derivatives and uses thereof | |
HUP0401162A3 (en) | Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives | |
AU2001276716A1 (en) | Cyclic amine derivatives and use thereof | |
HUP0202377A2 (en) | N-substituted perhydrodiazines, preparation and use thereof | |
AU7815201A (en) | Synthetic salicylihalamides, apicularens and derivatives thereof | |
AU2320400A (en) | Cyclic amine derivatives and uses thereof |